Guardian Pharmacy Services Inc. Class A Common Stock (NYSE: GRDN) Stock Analysis & Fundamentals

GRDNGuardian Pharmacy Services Inc. Class A Common Stock

NYSE · US · Healthcare · Medical Care Facilities · guardianpharmacy.com

37.63USD-0.91%Mkt Cap: 2.41B $P/E: 36.51Today

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualiz…

Industry Peers

Medical Care Facilities

Fresenius SE & Co. KGaA Inhaber-Aktien o.N.

$28.29BUSDP/E 16.7

THC

Tenet Healthcare Corporation

$21.62BUSDP/E 10.4

FME

Fresenius Medical Care AG & Co. KGaA

$11.94BUSDP/E 12.3

EHC

Encompass Health Corporation

The Ensign Group, Inc.

$10.64BUSDP/E 28.6

UHS

Universal Health Services, Inc. Class B

LifeStance Health Group Inc. Common Stock

$4.90BUSDP/E 98.7

CON

Concentra Group Holdings Parent Inc. Common Stock

National HealthCare Corporation

$3.67BUSDP/E 26.3

OPCH

Option Care Health, Inc.

$3.50BUSDP/E 17.7

BKD

Brookdale Senior Living Inc.

$2.89BUSD

AVAH

Aveanna Healthcare Holdings Inc.

Acadia Healthcare Company, Inc.

$2.55BUSD

ADUS

Addus HomeCare Corporation

$2.24BUSDP/E 21.0

Key Statistics

Company

Market Cap2.41B $

Enterprise Value2.34B $

Revenue (TTM)1.46B $

Gross Profit292.72M $

Net Income (TTM)49.22M $

Revenue/Share23.22 USD

Last Price37.63 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees3.6K

CountryUS

SectorHealthcare

IndustryMedical Care Facilities

ISIN—

Valuation

P/E (Trailing)36.51

P/E (Forward)26.21

PEG—

EV/EBITDA21.35

EV/Revenue1.60

P/S1.62

P/B10.75

EPS (TTM)1.03

EPS (Forward)1.43

52W Range

23.1461% of range47.02

52W High47.02 USD

52W Low23.14 USD

Profitability

Gross Margin20.21%

Oper. Margin3.48%

EBITDA Margin7.48%

Profit Margin3.40%

ROE23.92%

ROA11.93%

Growth

Revenue Growth2.20%

Earnings Growth139.80%

Cash Flow & Leverage

Operating CF100.25M $

CapEx (TTM)19.55M $

FCF Margin4.41%

FCF Yield2.68%

Net Debt-50.54M $

Net Debt/EBITDA-0.46

Balance Sheet

Debt/Equity0.18

Current Ratio1.65

Quick Ratio1.26

Book Value/Sh3.488 USD

Cash/Share1.418 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.2 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)48.83 USD

Upside (mean)+29.8%

Target Range47.00 USD – 50.00 USD

$47.00+29.8% to mean$50.00

# Analysts6

Ownership

Shares Out.49.80M

Float32.01M

Insiders37.51%

Institutions60.63%

Short Interest

Short Ratio7.9d

Short % Float7.69%

Short % Out.4.50%

Shares Short2.85M

Short (prev mo.)3.09M

Technical

SMA 5040.59 (-7.3%)

SMA 20035.29 (+6.6%)

Beta—

S&P 52W Chg18.16%

Avg Vol (30d)277.96K

Avg Vol (10d)444.55K

Technical Indicators

RSI (14)41.5

MACD-0.5727

MACD Signal-0.2335

MACD Hist.-0.3392

BB Upper43.09 USD

BB Middle40.11 USD

BB Lower37.13 USD

BB Width14.85%

ATR (14)1.997 USD

Vol Ratio (20d)0.62x